<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Wang W</submitter><funding>NIAID NIH HHS</funding><pubmed_abstract>Antigenic assessments of SARS-CoV-2 variants inform decisions to update COVID-19 vaccines. Primary infection sera are often used for assessments, but such sera are rare due to population immunity from SARS-CoV-2 infections and COVID-19 vaccinations. Here, we show that neutralization titers and breadth of matched human and hamster pre-Omicron variant primary infection sera correlate well and generate similar antigenic maps. The hamster antigenic map shows modest antigenic drift among XBB sub-lineage variants, with JN.1 and BA.4/BA.5 variants within the XBB cluster, but with five to six-fold antigenic differences between these variants and XBB.1.5. Compared to sera following only ancestral or bivalent COVID-19 vaccinations, or with post-vaccination infections, XBB.1.5 booster sera had the br</pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2024.04.05.588359</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11071293</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster sera.</pubmed_title><pmcid>PMC11071293</pmcid><funding_grant_id>Y01 AI005072</funding_grant_id><funding_grant_id>HHSN272201800013C</funding_grant_id><pubmed_authors>Goguet E</pubmed_authors><pubmed_authors>Selvaraj P</pubmed_authors><pubmed_authors>Lusvarghi S</pubmed_authors><pubmed_authors>Katzelnick LC</pubmed_authors><pubmed_authors>Bhushan GL</pubmed_authors><pubmed_authors>Paz S</pubmed_authors><pubmed_authors>Conte MA</pubmed_authors><pubmed_authors>Epsi NJ</pubmed_authors><pubmed_authors>Agan B</pubmed_authors><pubmed_authors>Stauft CB</pubmed_authors><pubmed_authors>Mitre E</pubmed_authors><pubmed_authors>Bishop-Lilly KA</pubmed_authors><pubmed_authors>Holbrook MR</pubmed_authors><pubmed_authors>Vassell R</pubmed_authors><pubmed_authors>Burgess TH</pubmed_authors><pubmed_authors>Weiss CD</pubmed_authors><pubmed_authors>Fung CK</pubmed_authors><pubmed_authors>Richard SA</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Cong Y</pubmed_authors><pubmed_authors>Pollett SD</pubmed_authors><pubmed_authors>Subramanian R</pubmed_authors><pubmed_authors>Wang TT</pubmed_authors><pubmed_authors>Fries A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster sera.</name><description>Antigenic assessments of SARS-CoV-2 variants inform decisions to update COVID-19 vaccines. Primary infection sera are often used for assessments, but such sera are rare due to population immunity from SARS-CoV-2 infections and COVID-19 vaccinations. Here, we show that neutralization titers and breadth of matched human and hamster pre-Omicron variant primary infection sera correlate well and generate similar antigenic maps. The hamster antigenic map shows modest antigenic drift among XBB sub-lineage variants, with JN.1 and BA.4/BA.5 variants within the XBB cluster, but with five to six-fold antigenic differences between these variants and XBB.1.5. Compared to sera following only ancestral or bivalent COVID-19 vaccinations, or with post-vaccination infections, XBB.1.5 booster sera had the br</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2026-07-01T03:14:35.727Z</modification><creation>2026-07-01T03:07:56.136Z</creation></dates><accession>S-EPMC11071293</accession><cross_references><pubmed>38712124</pubmed><doi>10.1101/2024.04.05.588359</doi></cross_references></HashMap>